Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study.
Journal for immunotherapy of cancer（2022）
摘要
NCT03380130.
更多查看译文
关键词
cytotoxicity, immunologic,immunotherapy,liver neoplasms,programmed cell death 1 receptor,radioimmunotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要